Since our last coverage of Invivo Therapeutics back in May, shares of NVIV have come down -23% from $1.23 to $0.94. However, the company is expanding the sites for its human clinical trials of Neuro-Spinal Scaffold treatment.
Digipath (OTC: DIGP) led the way in trading to close Mondays session with the stock climbing an eye watering 390% from open to close. After opening at $0.55 and trading to as high as $6.00 on the day the stock finally came to close at $2.50. This stock is sure to have a lot of trader’s eyes on it after recently raising more than $8 million to go ahead with their new venture in the cannabis industry.
Immune Pharmaceuticals (IMNP) broke out of its recent range to surprise many investors by maintaining its recent strength as shares continue to move higher.
So, here is a bulletin board company that is taking on the likes of Google Glass. The whole idea is to bring your entire life right in front of your eyes at the switch of a button and this small NY based company is looking to grab a slice of the pie.
Since hitting a recent low in the markets on July 8th shares in Nuvilex (NVLX) have been moving higher on a consistent basis. We have seen a small pullback since the recent high set above $0.40 but over the last 2 weeks the general direction has been higher.
Since the beginning of the year, shares of OOIL have been on a downtrend reaching it’s all time low of $0.138 on June 6th. It has then come back up and down until the most recent rebound on July 18th, when shares rose from $0.159 to the current levels of $0.198. We haven’t seen these levels since April.